BMJ, doi: 10.1136/bmj.38082.626725.EE, (Published 4 May 2004)

PRIMARY CARE

Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project

Richard F Harvey ¹, J Athene Lane ², Liam J Murray ³, Ian M Harvey ⁴, Jenny L Donovan ², Prakash Nair ⁵

¹ Frenchay Hospital, North Bristol NHS Trust, Bristol BS16 1LE
² Department of Social Medicine, University of Bristol, Bristol BS8 2PR
³ Department of Epidemiology and Public Health, The Queen's University of Belfast, Belfast BT9 5EE
⁴ School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ
⁵ Peterborough General Hospital, Peterborough

Objectives To investigate the effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux.

Design Cross sectional study, followed by a randomised placebo controlled trial.

Setting Seven general practices in Bristol, England.

Participants 10 537 people, aged 20-59 years, with and without H pylori infection (determined by the ¹³C-urea breath test).

Main outcome measures Prevalence of heartburn and gastro-oesophageal acid reflux at baseline and two years after treatment to eradicate H pylori infection.

Results At baseline, H pylori infection was associated with increased prevalence of heartburn (odds ratio 1.14, 95% confidence interval 1.05 to 1.23) but not reflux (1.05, 0.97 to 1.14). In participants with H pylori infection, active treatment had no effect on the overall prevalence of heartburn (0.99, 0.88 to 1.12) or reflux (1.04, 0.91 to 1.19) and did not improve pre-existing symptoms of heartburn or reflux.

ConclusionsH pylori infection is associated with a slightly increased prevalence of heartburn but not reflux. Treatment to eradicate H pylori has no net benefit in patients with heartburn or gastro-oesophageal reflux.

---

(Accepted 12 March 2004)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Dyspepsia and Helicobacter pylori

Rupal Shah
BMJ 2007 334: 41-43. [Extract] [Full Text] [PDF]

Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial

J Athene Lane, Liam J Murray, Sian Noble, Matthias Egger, Ian M Harvey, Jenny L Donovan, Prakash Nair, and Richard F Harvey
BMJ 2006 332: 199-204. [Abstract] [Full Text] [PDF]

Helicobacter pylori and gastro-oesophageal reflux disease: Information on underlying pathology is not given

Giovanni Cammarota and Giovanni B Gasbarrini
BMJ 2004 329: 402. [Extract] [Full Text]

Helicobacter pylori and gastro-oesophageal reflux disease: Important data were not presented

Ian L P Beales
BMJ 2004 329: 402. [Extract] [Full Text]

Does eradicating H pylori improve gastric symptoms?
BMJ 2004 328: 0. [Full Text]

Do mistakes matter?

Kamran Abbasi
BMJ 2004 328: 0. [Extract] [Full Text] [PDF]

Eradicating H pylori

Brendan Delaney and Paul Moayyedi
BMJ 2004 328: 1388-1389. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Lee, Y.-C., Lin, J.-T., Wu, H.-M., Liu, T.-Y., Yen, M.-F., Chiu, H.-M., Wang, H.-P., Wu, M.-S., Hsiu-Hsi Chen, T. (2007). Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer. Cancer Epidemiol. Biomarkers Prev. 16: 875-885 [Abstract] [Full text]  
• Shah, R. (2007). Dyspepsia and Helicobacter pylori. BMJ 334: 41-43 [Full text]  
• Lane, J A., Murray, L. J, Noble, S., Egger, M., Harvey, I. M, Donovan, J. L, Nair, P., Harvey, R. F (2006). Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial. BMJ 332: 199-204 [Abstract] [Full text]  
• Bartlett, J. G. (2006). Update in Infectious Diseases. ANN INTERN MED 144: 49-56 [Full text]  
• (2005). H. pylori eradication in NSAID-associated ulcers. DTB 43: 37-40 [Abstract] [Full text]  
• (2004). ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB. Evid. Based Med. 9: 163-163 [Full text]  
• (2004). 23 Apr 2004 to 23 Jul 2004. Evid. Based Nurs. 7: e4-e4 [Full text]  
• Cammarota, G., Gasbarrini, G. B (2004). Helicobacter pylori and gastro-oesophageal reflux disease: Information on underlying pathology is not given. BMJ 329: 402-402 [Full text]  
• Beales, I. L P (2004). Helicobacter pylori and gastro-oesophageal reflux disease: Important data were not presented. BMJ 329: 402-402 [Full text]  
• Delaney, B., Moayyedi, P. (2004). Eradicating H pylori. BMJ 328: 1388-1389 [Full text]  

Rapid Responses:

Read all Rapid Responses

Helicobacter pylori and gastro-oesophageal reflux disease

Giovanni Cammarota, et al.
bmj.com, 12 Jun 2004 [Full text]

Does the study tell us about gastro-oesophageal reflux disease?

Ian L. P. Beales
bmj.com, 19 Jun 2004 [Full text]

Online poll

Find out more here>> and here>>